Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ILPT
3201
Industrial Logistics Properties Trust
ILPT
$476M
| $461K | ﹤0.01% |
81,221
-72,732
| -47% | -$423K |
2018 Q1
32 quarters
|
|
|
SMA
3202
SmartStop Self Storage REIT
SMA
$1.79B
| $461K | ﹤0.01% |
15,225
-33,401
| -69% | -$1.07M |
2025 Q2
3 quarters
|
|
3203
Zymeworks
ZYME
$1.81B
| $460K | ﹤0.01% |
18,374
-61,592
| -77% | -$1.46M |
2023 Q4
9 quarters
|
|
3204
St. Joe Company
JOE
$3.74B
| $458K | ﹤0.01% |
7,299
-52,089
| -88% | -$3.49M |
2013 Q2
51 quarters
|
|
3205
Neuropace
NPCE
$444M
| $458K | ﹤0.01% |
34,845
-33,710
| -49% | -$506K |
2022 Q1
16 quarters
|
|
3206
CALL
Viasat
VSAT
$10B
| $458K | ﹤0.01% |
+10,000
| New | +$450K |
2026 Q1
0 quarters
|
|
3207
Neogen
NEOG
$2.7B
| $457K | ﹤0.01% |
49,212
-312,047
| -86% | -$3.07M |
2016 Q2
39 quarters
|
|
3208
Varex Imaging
VREX
$785M
| $457K | ﹤0.01% |
43,082
-72,981
| -63% | -$932K |
2017 Q1
36 quarters
|
|
3209
Unity Bancorp
UNTY
$554M
| $456K | ﹤0.01% |
8,800
-9,316
| -51% | -$491K |
2017 Q1
36 quarters
|
|
|
CALY
3210
Callaway Golf Company
CALY
$2.59B
| $454K | ﹤0.01% |
32,732
-277,510
| -89% | -$3.89M |
2016 Q1
40 quarters
|
|
3211
Tango Therapeutics
TNGX
$3.95B
| $453K | ﹤0.01% |
21,670
-346,517
| -94% | -$4.82M |
2022 Q1
16 quarters
|
|
|
ONTF
3212
DELISTED
ON24
ONTF
| $453K | ﹤0.01% |
55,949
-78,317
| -58% | -$626K |
2022 Q1
16 quarters
|
|
3213
National Vision
EYE
$1.31B
| $452K | ﹤0.01% |
17,469
-108,439
| -86% | -$2.95M |
2017 Q4
33 quarters
|
|
3214
Photronics
PLAB
$1.85B
| $452K | ﹤0.01% |
11,181
-81,437
| -88% | -$2.95M |
2013 Q2
51 quarters
|
|
3215
AngioDynamics
ANGO
$641M
| $451K | ﹤0.01% |
39,626
-53,065
| -57% | -$575K |
2013 Q2
51 quarters
|
|
3216
Relay Therapeutics
RLAY
$4.12B
| $450K | ﹤0.01% |
45,267
-368,876
| -89% | -$3.3M |
2022 Q1
16 quarters
|
|
3217
First Mid Bancshares
FMBH
$1.32B
| $450K | ﹤0.01% |
10,923
-33,645
| -75% | -$1.39M |
2016 Q2
39 quarters
|
|
3218
Seneca Foods Class A
SENEA
$1.2B
| $449K | ﹤0.01% |
2,974
-5,064
| -63% | -$654K |
2016 Q1
40 quarters
|
|
3219
PUT
ResMed
RMD
$31.8B
| $449K | ﹤0.01% |
2,000
-87,500
| -98% | -$21.8M |
2024 Q3
6 quarters
|
|
3220
Douglas Emmett
DEI
$1.65B
| $445K | ﹤0.01% |
47,265
-214,473
| -82% | -$2.21M |
2013 Q2
51 quarters
|
|
3221
Aurinia Pharmaceuticals
AUPH
$2.11B
| $445K | ﹤0.01% |
30,000
-156,140
| -84% | -$2.28M |
2019 Q1
28 quarters
|
|
|
JCAP
3222
Jefferson Capital
JCAP
$1.13B
| $444K | ﹤0.01% |
23,074
+4,450
| +24% | +$94.1K |
2025 Q2
3 quarters
|
|
3223
Celldex Therapeutics
CLDX
$2.52B
| $443K | ﹤0.01% |
13,975
-226,619
| -94% | -$6.18M |
2020 Q2
23 quarters
|
|
3224
Horace Mann Educators
HMN
$1.83B
| $443K | ﹤0.01% |
10,380
-54,135
| -84% | -$2.34M |
2013 Q2
51 quarters
|
|
|
EFSI
3225
Eagle Financial Services Inc
EFSI
$247M
| $442K | ﹤0.01% |
12,647
-6,050
| -32% | -$224K |
2025 Q2
3 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.